Tim Hardman

Dr Tim Hardman is Founder and Managing Director of Niche Science & Technology Ltd., the UK-based CRO he established in 1998 to provide tailored, science-driven support to pharmaceutical and biotech companies. With more than 25 years’ experience in clinical research, he has built Niche into a trusted early-phase development partner for start-ups and established companies worldwide. Tim is Chairman of the Association of Human Pharmacology in the Pharmaceutical Industry (AHPPI) and a Board member and former President of EUFEMED (2021–2023). He also contributes to the Pharmaceutical Contract Management Group (PCMG) and holds an honorary fellowship at St George’s Medical School. He regularly comments on clinical research, regulatory innovation and AI.